Fibroblast Growth Factor 23 in Patients Undergoing Peritoneal Dialysis

SUMMARY: BACKGROUND AND OBJECTIVES: Fibroblast growth factor 23 (FGF23) is an independent risk factor for mortality in patients with ESRD. Before FGF23 testing can be integrated into clinical practice of ESRD, further understanding of its determinants is needed. DESIGN, SETTING, PARTICIPANTS, &...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Isakova, Tamara, Xie, Huiliang, Barchi-Chung, Allison, Vargas, Gabriela, Sowden, Nicole, Houston, Jessica, Wahl, Patricia, Lundquist, Andrew, Epstein, Michael, Smith, Kelsey, Contreras, Gabriel, Ortega, Luis, Lenz, Oliver, Briones, Patricia, Egbert, Phyllis, Ikizler, T. Alp, Jueppner, Harald, Wolf, Myles
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Nephrology 2011
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3206004/
https://ncbi.nlm.nih.gov/pubmed/21903990
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.04290511
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados